Aggressive MELD-Exception Advocacy: When Caregivers Need to Push
Some patients only get listed, or get MELD exception points, because a caregiver keeps pushing. Here is when that happens and how to push the right way.
Some transplant centers are known among coordinators and hepatologists to need consistent caregiver advocacy to get certain patients listed and approved — particularly Medicaid recipients and patients whose MELD doesn't reflect their true clinical urgency.
This is not a criticism of those centers. It reflects insurance and financial pressure, selection-committee culture, payer mix, and the structural reality that listing decisions are committee decisions.
How listing and exception decisions are actually made
Two different groups make two different decisions, and it helps to know which one you are dealing with.
- Your center's selection committee decides whether you are listed at all. This is a meeting of surgeons, hepatologists, coordinators, social workers, financial staff and others at the center. They review your test results, your support plan and your insurance. See liver transplant criteria for what they look at.
- The National Liver Review Board decides on MELD exception points. Since May 2019, exception requests no longer go to a regional board. Your center writes a request explaining why your MELD score understates how sick you are, and a national panel of transplant doctors and surgeons from other programs reviews it. There are separate review boards for liver cancer (HCC), other adult diagnoses, and children.
So "advocacy" means two things: making sure your center brings your case to its selection committee with a complete file, and making sure your center actually submits — and, if needed, re-submits — a well-documented exception request. Your center has to file the request. You cannot file it yourself.
Patients who often need advocacy
- Medicaid recipients at centers with low historical Medicaid acceptance rates
- HCC (liver cancer) patients within Milan criteria who haven't been approved for MELD exception
- Refractory ascites (fluid that keeps coming back) or hepatic encephalopathy (HE, confusion from liver failure) requiring frequent intervention with persistently low MELD
- Pediatric patients with growth failure as the primary clinical sign (children are scored with PELD, the pediatric version of MELD)
- Patients with rare causes of liver disease, such as primary sclerosing cholangitis (PSC), autoimmune hepatitis with HE, or Budd-Chiari syndrome (BCS)
Insurance and social factors matter in real data, not just in stories. In one study of 521 patients with cirrhosis at three safety-net hospitals, fewer than one in three patients with a MELD-Na score of 15 or higher were referred for transplant, and insurance problems were the reason listed for about one in five of the patients who were not referred. A separate study found that candidates with Medicaid were less likely than privately insured candidates to move from referral to evaluation. Those numbers come from specific hospitals and are not national rates, but they show why someone needs to keep the process moving.
What advocacy looks like
- Step 1 — Bring complete medical records to every visit: labs, imaging, hospital discharge summaries, prior consult notes. Keep a copy in a binder or a shared folder. Our transplant checklist can help you organize it.
- Step 2 — Ask when the selection committee meets and when your case is on the agenda, so you know when your case is being reviewed. If an exception request is planned, ask when it will be submitted.
- Step 3 — Request the specific reason for any "not listed yet" decision in writing. Vague answers ("we're waiting for more data") are not actionable; specific answers ("MELD trajectory needs three more months") are.
- Step 4 — Engage the center's social worker and patient advocate. They often have channels the medical team doesn't, especially for insurance, housing and caregiver-plan problems.
- Step 5 — Escalate respectfully. If you're stuck, ask whether a second-opinion evaluation at another center is reasonable.
- Step 6 — Document everything. Names, dates, what was said.
Questions to ask your transplant team
- "Is my case on the selection committee agenda? When?"
- "Does my MELD score reflect how sick I am? If not, will you submit an exception request to the National Liver Review Board?"
- "If an exception request was denied, what was the reason, and can it be appealed or re-submitted with new information?"
- "What exactly do you need from me — tests, a caregiver plan, insurance approval — before you will list me?"
- "Has my insurance approved evaluation and transplant at this center? Who is my financial coordinator?"
- "Would you support me being evaluated at a second center?"
Write down the answers and the name of the person who gave them.
Common misconceptions
- "Pushing will make the team dislike us." Polite, organized follow-up is normal. Teams handle many patients at once, and a well-organized caregiver often makes their job easier. Be firm, be courteous, and keep it in writing.
- "A low MELD means I'm not sick enough to matter." MELD measures the risk of dying soon based on lab values. It does not capture every problem, which is exactly why exception points exist. Read our explainer on whole-patient vs. strict-MELD listing.
- "We can apply for exception points ourselves." You can't. Only your transplant center can submit a request, which is why you need them to do it well.
- "If one center says no, the answer is no." Centers differ in how they evaluate patients. A "no" at one program is not a "no" everywhere.
When to look at a second center
If you're not making progress, being evaluated and listed at a second whole-patient program is a legitimate option to discuss with your hepatologist. Livers are offered first to the most urgent patients at centers inside circles drawn around the donor hospital (called acuity circles), so a second center in a different part of the country can receive different offers. Our dual-listing page and step-by-step dual-listing guide explain how it works, and the center comparison map lets you compare programs. Always confirm with your insurance first — see why you always have to call.
Caregiving and advocacy are hard work. Our caregiver hub has support for you, too.
Sources
- Liver transplant allocation policies and outcomes in the United States: a comprehensive review (World J Methodol, 2022) — National Liver Review Board structure and acuity-circle allocation
- The role of exception points in outcomes of patients with fibrocystic liver-kidney disease (Liver Transpl, 2024) — National Liver Review Board start date of May 14, 2019
- Factors associated with liver transplant referral among patients with cirrhosis at multiple safety-net hospitals (JAMA Netw Open, 2023)
- Access to early liver transplantation is adversely impacted by social determinants of health (Liver Transpl, 2025)
- NIDDK: Liver Transplant
Educational only. Not medical advice. Your transplant team has the final word.
